The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
MYC protein interactors in gene transcription and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Coactivator condensation at super-enhancers links phase separation and gene control
Sabari, B. R., Dall’Agnese, A., Boija, A., Klein, I. A., Coffey, E. L., Shrinivas, K., Abraham, B. J., Hannett, N. M., Zamudio, A. V., Manteiga, J. C., et al. (2018) · Science · doi:10.1126/science.aar3958 · Cited by 2,595
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Boija, A., Klein, I. A., Sabari, B. R., Dall’Agnese, A., Coffey, E. L., Zamudio, A. V., Li, C. H., Shrinivas, K., Manteiga, J. C., Hannett, N. M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.042 · Cited by 1,815
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Self-citationTranscriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,291
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Transcriptional Addiction in Cancer
Bradner, J. E., Hnisz, D., & Young, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.12.013 · Cited by 1,194
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.033 · Cited by 1,075
Drugging the ‘undruggable’ cancer targets
Dang, C. V., Reddy, E. P., Shokat, K. M., & Soucek, L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.36 · Cited by 927
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Jin, Q., Yu, L., Wang, L., Zhang, Z., Kasper, L. H., Lee, J., Wang, C., Brindle, P. K., Dent, S. Y. R., & Ge, K. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.318 · Cited by 877
Getting up to speed with transcription elongation by RNA polymerase II
Jonkers, I., & Lis, J. T. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3953 · Cited by 876
Coupling mRNA processing with transcription in time and space
Bentley, D. L. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3662 · Cited by 828
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693
Pol II phosphorylation regulates a switch between transcriptional and splicing condensates
Guo, Y. E., Manteiga, J. C., Henninger, J. E., Sabari, B. R., Dall’Agnese, A., Hannett, N. M., Spille, J.-H., Afeyan, L. K., Zamudio, A. V., Shrinivas, K., et al. (2019) · Nature · doi:10.1038/s41586-019-1464-0 · Cited by 673
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Chipumuro, E., Marco, E., Christensen, C. L., Kwiatkowski, N., Zhang, T., Hatheway, C. M., Abraham, B. J., Sharma, B., Yeung, C., Altabef, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.024 · Cited by 631
Doyon, Y., Selleck, W., Lane, W. S., Tan, S., & Côté, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.1884-1896.2004 · Cited by 597
Defining mechanisms that regulate RNA polymerase II transcription in vivo
Fuda, N. J., Ardehali, M. B., & Lis, J. T. (2009) · Nature · doi:10.1038/nature08449 · Cited by 576
Repression of p15INK4b expression by Myc through association with Miz-1
Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Möröy, T., Bartek, J., Massagué, J., Hänel, F., et al. (2001) · Nature Cell Biology · doi:10.1038/35070076 · Cited by 575
Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II
Lu, H., Yu, D., Hansen, A. S., Ganguly, S., Liu, R., Heckert, A., Darzacq, X., & Zhou, Q. (2018) · Nature · doi:10.1038/s41586-018-0174-3 · Cited by 573
Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation
Core, L., & Adelman, K. (2019) · Genes & Development · doi:10.1101/gad.325142.119 · Cited by 568
Oncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA
Nair, S. K., & Burley, S. K. (2003) · Cell · doi:10.1016/s0092-8674(02)01284-9 · Cited by 551
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494
Liang, G., Lin, J. C. Y., Wei, V., Yoo, C., Cheng, J. C., Nguyen, C. T., Weisenberger, D. J., Egger, G., Takai, D., Gonzales, F. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401866101 · Cited by 484
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Wang, Y., Zhang, T., Kwiatkowski, N., Abraham, B. J., Lee, T. I., Xie, S., Yuzugullu, H., Von, T., Li, H., Lin, Z., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.063 · Cited by 465
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Han, H., Jain, A. D., Truica, M. I., Izquierdo-Ferrer, J., Anker, J. F., Lysy, B., Sagar, V., Luan, Y., Chalmers, Z. R., Unno, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.001 · Cited by 465
MYC Deregulation in Primary Human Cancers
Kalkat, M., De Melo, J., Hickman, K., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W., & Penn, L. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 443
Self-citationTargeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.019 · Cited by 439
Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3
Gartel, A. L., Ye, X., Goufman, E., Shianov, P., Hay, N., Najmabadi, F., & Tyner, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074898 · Cited by 417
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 412
MYC recruits the TIP60 histone acetyltransferase complex to chromatin
Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H., Livingston, D. M., & Amati, B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor861 · Cited by 405
Myc influences global chromatin structure
Knoepfler, P. S., Zhang, X., Cheng, P. F., Gafken, P. R., McMahon, S. B., & Eisenman, R. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601152 · Cited by 383
In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes.
Rasmussen, E. B., & Lis, J. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7923 · Cited by 364
Glover-Cutter, K., Larochelle, S., Erickson, B., Zhang, C., Shokat, K., Fisher, R. P., & Bentley, D. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00637-09 · Cited by 350
Analysis of genomic targets reveals complex functions of MYC
Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C., & McMahon, S. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1393 · Cited by 312
Target gene-independent functions of MYC oncoproteins
Baluapuri, A., Wolf, E., & Eilers, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0215-2 · Cited by 310
Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC
Thomas, L. R., Wang, Q., Grieb, B. C., Phan, J., Foshage, A. M., Sun, Q., Olejniczak, E. T., Clark, T., Dey, S., Lorey, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.028 · Cited by 310
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Soucek, L., Whitfield, J. R., Sodir, N. M., Massó-Vallés, D., Serrano, E., Karnezis, A. N., Swigart, L. B., & Evan, G. I. (2013) · Genes & Development · doi:10.1101/gad.205542.112 · Cited by 301
Strategies to Inhibit Myc and Their Clinical Applicability
Whitfield, J. R., Beaulieu, M.-E., & Soucek, L. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00010 · Cited by 294
The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis
Carroll, P. A., Freie, B. W., Mathsyaraja, H., & Eisenman, R. N. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0650-z · Cited by 289
Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes
Zamudio, A. V., Dall’Agnese, A., Henninger, J. E., Manteiga, J. C., Afeyan, L. K., Hannett, N. M., Coffey, E. L., Li, C. H., Oksuz, O., Sabari, B. R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.016 · Cited by 283
Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP
Vervoorts, J., Lüscher‐Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M., & Lüscher, B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor821 · Cited by 281
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
Cang, S., Iragavarapu, C., Savooji, J., Song, Y., & Liu, D. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0224-3 · Cited by 281
Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter
Eberhardy, S. R., & Farnham, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207441200 · Cited by 262
The MYC oncogene is a global regulator of the immune response
Casey, S. C., Baylot, V., & Felsher, D. W. (2018) · Blood · doi:10.1182/blood-2017-11-742577 · Cited by 259
Clinical trials for BET inhibitors run ahead of the science
Andrieu, G., Belkina, A. C., & Denis, G. V. (2016) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2016.06.004 · Cited by 247
Emerging roles of Myc in stem cell biology and novel tumor therapies
Yoshida, G. J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0835-y · Cited by 241
Alqahtani, A., Choucair, K., Ashraf, M., Hammouda, D. M., Alloghbi, A., Khan, T., Senzer, N., & Nemunaitis, J. (2019) · Future Science OA · doi:10.4155/fsoa-2018-0115 · Cited by 240
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes
Gartel, A. L., & Shchors, K. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00020-4 · Cited by 238
Venetoclax: First Global Approval
Deeks, E. D. (2016) · Drugs · doi:10.1007/s40265-016-0596-x · Cited by 236
Cortazar, M. A., Sheridan, R. M., Erickson, B., Fong, N., Glover-Cutter, K., Brannan, K., & Bentley, D. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.031 · Cited by 227
Design and properties of a Myc derivative that efficiently homodimerizes
Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., & Nasi, S. (1998) · Oncogene · doi:10.1038/sj.onc.1202199 · Cited by 221
Transcriptional repression by Myc
Wanzel, M., Herold, S., & Eilers, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00003-5 · Cited by 216
c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism
Eberhardy, S. R., & Farnham, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109014200 · Cited by 215
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
Beaulieu, M.-E., Jauset, T., Massó-Vallés, D., Martínez-Martín, S., Rahl, P., Maltais, L., Zacarias-Fluck, M. F., Casacuberta-Serra, S., Serrano del Pozo, E., Fiore, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5012 · Cited by 209
Kalkat, M., Resetca, D., Lourenco, C., Chan, P.-K., Wei, Y., Shiah, Y.-J., Vitkin, N., Tong, Y., Sunnerhagen, M., Done, S. J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.031 · Cited by 201
Self-citationMyc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
Annibali, D., Whitfield, J. R., Favuzzi, E., Jauset, T., Serrano, E., Cuartas, I., Redondo-Campos, S., Folch, G., Gonzàlez-Juncà, A., Sodir, N. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5632 · Cited by 200
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
Huang, C.-H., Lujambio, A., Zuber, J., Tschaharganeh, D. F., Doran, M. G., Evans, M. J., Kitzing, T., Zhu, N., de Stanchina, E., Sawyers, C. L., et al. (2014) · Genes & Development · doi:10.1101/gad.244368.114 · Cited by 198
Mammalian MYC Proteins and Cancer
Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 196
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
Beeson, J. G., Kurtovic, L., Dobaño, C., Opi, D. H., Chan, J.-A., Feng, G., Good, M. F., Reiling, L., & Boyle, M. J. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1458 · Cited by 191
Improved low molecular weight Myc-Max inhibitors
Wang, H., Hammoudeh, D. I., Follis, A. V., Reese, B. E., Lazo, J. S., Metallo, S. J., & Prochownik, E. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0005 · Cited by 190
Patel, M. C., Debrosse, M., Smith, M., Dey, A., Huynh, W., Sarai, N., Heightman, T. D., Tamura, T., & Ozato, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01180-12 · Cited by 183
c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis
Kanazawa, S., Soucek, L., Evan, G., Okamoto, T., & Peterlin, B. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206800 · Cited by 181
Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors
Richards, M. W., Burgess, S. G., Poon, E., Carstensen, A., Eilers, M., Chesler, L., & Bayliss, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610626113 · Cited by 180
BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis
Richart, L., Pau, E. C. D. S., Rio‐Machín, A., de Andrés, M. P., Cigudosa, J. C., Lobo, V. J. S.-A., & Real, F. X. (2016) · Nature Communications · doi:10.1038/ncomms10153 · Cited by 164
Moonlighting with WDR5: A Cellular Multitasker
Guarnaccia, A. D., & Tansey, W. P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020021 · Cited by 164
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek, L., Jucker, R., Panacchia, L., Ricordy, R., Tatò, F., & Nasi, S. (2002) · PubMed · Cited by 160
Inhibitor of MYC identified in a Kröhnke pyridine library
Hart, J. R., Garner, A. L., Yu, J., Ito, Y., Sun, M., Ueno, L. A., Rhee, J., Baksh, M. M., Stefan, E., Hartl, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319488111 · Cited by 159
Zhang, X., Chen, X., Lin, J., Lwin, T., Wright, G. M., Moscinski, L. C., Dalton, W. S., Seto, E., Wright, K., Sotomayor, E. M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.470 · Cited by 156
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
Allen-Petersen, B. L., & Sears, R. C. (2019) · BioDrugs · doi:10.1007/s40259-019-00370-5 · Cited by 156
Cowling, V. H., & Cole, M. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01828-06 · Cited by 155
Myc represses the growth arrest gene gadd45
Marhin, W. W., Chen, S., Facchini, L. M., Fornace, A. J., & Penn, L. Z. (1997) · Oncogene · doi:10.1038/sj.onc.1201138 · Cited by 152
Self-citationAnalysis of Myc-Induced Histone Modifications on Target Chromatin
Martinato, F., Cesaroni, M., Amati, B. B., & Guccione, E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003650 · Cited by 151
Carugo, A., Genovese, G., Seth, S., Nezi, L., Rose, J. L., Bossi, D., Cicalese, A., Shah, P. K., Viale, A., Pettazzoni, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.063 · Cited by 151
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
Massó-Vallés, D., & Soucek, L. (2020) · Cells · doi:10.3390/cells9040883 · Cited by 149
Myc and its interactors take shape
Tu, W. B., Helander, S., Pilstål, R., Hickman, K. A., Lourenco, C., Jurišica, I., Raught, B., Wallner, B., Sunnerhagen, M., & Penn, L. Z. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.06.002 · Cited by 142
Self-citationHateboer, G., Timmers, H. T. M., Rustgi, A., Billaud, M., Veer, L. V. ‘., & Bernards, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8489 · Cited by 142
Taming of the beast: shaping Myc-dependent amplification
Wolf, E., Lin, C. Y., Eilers, M., & Levens, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.006 · Cited by 139
Castell, A., Yan, Q., Fawkner, K., Hydbring, P., Zhang, F., Verschut, V., Franco, M., Zakaria, S. M., Bazzar, W., Goodwin, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28107-4 · Cited by 139
MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation
Baluapuri, A., Hofstetter, J., Dudvarski Stankovic, N., Endres, T., Bhandare, P., Vos, S. M., Adhikari, B., Schwarz, J. D., Narain, A., Vogt, M., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.031 · Cited by 138
The Myc trilogy: lord of RNA polymerases
Óskarsson, T., & Trumpp, A. (2005) · Nature Cell Biology · doi:10.1038/ncb0305-215 · Cited by 135
Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase
Kurland, J. F., & Tansey, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6552 · Cited by 135
Regulation and Function of Cdt1; A Key Factor in Cell Proliferation and Genome Stability
Pozo, P. N., & Cook, J. G. (2016) · Genes · doi:10.3390/genes8010002 · Cited by 134
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
Dingar, D., Kalkat, M., Chan, P.-K., Srikumar, T., Bailey, S. D., Tu, W. B., Coyaud, E., Ponzielli, R., Kolyar, M., Jurisica, I., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2014.09.029 · Cited by 131
Self-citationA Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers
Jung, M., Russell, A. J., Liu, B., George, J., Liu, P. Y., Liu, T., DeFazio, A., Bowtell, D. D. L., Oberthuer, A., London, W. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2906 · Cited by 129
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding
Andrésen, C., Helander, S., Lemak, A. S., Farès, C., Csizmók, V., Carlsson, J., Penn, L. Z., Forman-Kay, J. D., Arrowsmith, C. H., Lundström, P., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks263 · Cited by 128
Self-citationPineda‐Lucena, A., Ho, C. S. W., Mao, D. Y. L., Sheng, Y., Laister, R. C., Muhandiram, R., Lü, Y., Seet, B. T., Katz, S., Szyperski, T., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.05.046 · Cited by 128
Self-citationSun, Y., Bell, J. L., Carter, D. R., Gherardi, S., Poulos, R. C., Milazzo, G., Wong, J. W. H., Al‐awar, R., Tee, A. E., Liu, P. Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0423 · Cited by 125
Self-citationTargeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy
Liang, K., Smith, E. R., Aoi, Y., Stoltz, K. L., Katagi, H., Woodfin, A. R., Rendleman, E. J., Marshall, S. A., Murray, D. C., Wang, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.027 · Cited by 124
Thomas, L. R., Adams, C. M., Wang, J., Weissmiller, A. M., Creighton, J. H., Lorey, S. L., Liu, Q., Fesik, S. W., Eischen, C. M., & Tansey, W. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910391116 · Cited by 124
Guo, J., Parise, R. A., Joseph, E., Egorin, M. J., Lazo, J. S., Prochownik, E. V., & Eiseman, J. L. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0774-y · Cited by 123
Tu, W. B., Shiah, Y.-J., Lourenco, C., Mullen, P. J., Dingar, D. D., Redel, C., Tamachi, A., Ba-Alawi, W., Aman, A. M., Al‐awar, R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.09.001 · Cited by 121
Self-citationMYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III
Campbell, K. J., & White, R. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018408 · Cited by 113
McEwan, I. J., Dahlman‐Wright, K., Ford, J., & Wright, A. P. H. (1996) · Biochemistry · doi:10.1021/bi960793v · Cited by 109
Singleton, K. R., Crawford, L. A., Tsui, E. L., Manchester, H. E., Maertens, O., Liu, X., Liberti, M. V., Magpusao, A. N., Stein, E. M., Tingley, J. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.022 · Cited by 109
P-TEFb is a Crucial Co-Factor for Myc Transactivation
Gargano, B., Amente, S., Majello, B., & Lania, L. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4554 · Cited by 102
Khurana, A., & Shafer, D. A. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s172315 · Cited by 102
Jung, L. A., Gebhardt, A., Koelmel, W., Ade, C. P., Walz, S., Kuper, J., von Eyss, B., Letschert, S., Redel, C., d'Artista, L., et al. (2017) · Oncogene · doi:10.1038/onc.2016.354 · Cited by 101
Self-citationPopay, T. M., Wang, J., Adams, C. M., Howard, G. C., Codreanu, S. G., Sherrod, S. D., MCLEAN, J. A. J., Thomas, L. R., Lorey, S. L., Machida, Y., et al. (2021) · eLife · doi:10.7554/elife.60191 · Cited by 99
Sequence specificity incompletely defines the genome-wide occupancy of Myc
Guo, J., Li, T., Schipper, J. L., Nilson, K. A., Fordjour, F. K., Cooper, J. J., Gordân, R., & Price, D. H. (2014) · Genome biology · doi:10.1186/s13059-014-0482-3 · Cited by 98
Activation by c-Myc of transcription by RNA polymerases I, II and III
Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., Ramsbottom, B. A., Innes, F., Kantidakis, T., Kerr, E. R., et al. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730141 · Cited by 95
Inhibition of MYC by the SMARCB1 tumor suppressor
Weissmiller, A. M., Wang, J., Lorey, S. L., Howard, G. C., Martinez, E., Liu, Q., & Tansey, W. P. (2019) · Nature Communications · doi:10.1038/s41467-019-10022-5 · Cited by 92
Pharmacophore identification of c-Myc inhibitor 10074-G5
Yap, J. L., Wang, H., Hu, A., Chauhan, J., Jung, K.-Y., Gharavi, R. B., Prochownik, E. V., & Fletcher, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.013 · Cited by 91
Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
Stellas, D., Szabolcs, M. J., Koul, S., Li, Z., Polyzos, A., Anagnostopoulos, C., Cournia, Z., Tamvakopoulos, C., Klinakis, A., & Efstratiadis, A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju320 · Cited by 89
Guo, C., Che, Z., Yue, J., Xie, P., Hao, S., Xie, W., Luo, Z., & Lin, C. (2020) · Science Advances · doi:10.1126/sciadv.aay4858 · Cited by 86
Maheswaran, S., Lee, H., & Sonenshein, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1147 · Cited by 81
Bagratuni, T., Mavrianou, N., Gavalas, N. G., Tzannis, K., Arapinis, C., Liontos, M., Christodoulou, M., Thomakos, N., Haidopoulos, D. A., Rodolakis, A., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.11.017 · Cited by 79
Omomyc expression in skin prevents Myc-induced papillomatosis
Soucek, L., Nasi, S., & Evan, G. I. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401443 · Cited by 77
Jp, M., Dc, H., Littlewood, T. D., & Evan, G. I. (1987) · PubMed · Cited by 76
Distinct Mechanisms of Transcription Initiation by RNA Polymerases I and II
Engel, C., Neyer, S., & Cramer, P. (2018) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070317-033058 · Cited by 76
Chacón Simon, S., Wang, F., Thomas, L. R., Phan, J., Zhao, B., Olejniczak, E. T., Macdonald, J. D., Shaw, J. G., Schlund, C., Payne, W., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00224 · Cited by 76
Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors
Cole, M. D., & Cowling, V. H. (2009) · Oncogene · doi:10.1038/onc.2008.463 · Cited by 75
THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
Lu, P., Geng, J., Zhang, L., Wang, Y., Niu, N., Fang, Y., Liu, F., Shi, J., Zhang, Z., Sun, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0701-1 · Cited by 73
Inactivation of MYC reverses tumorigenesis
Li, Y., Casey, S. C., & Felsher, D. W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12237 · Cited by 72
Blake, D. R., Vaseva, A. V., Hodge, R. G., Kline, M. P., Gilbert, T. S. K., Tyagi, V., Huang, D., Whiten, G. C., Larson, J. E., Wang, X., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav7259 · Cited by 72
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
Hashiguchi, T., Bruss, N., Best, S., Lam, V., Danilova, O. V., Paiva, C. J., Wolf, J., Gilbert, E. W., Okada, C. Y., Kaur, P., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1023 · Cited by 71
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
Otto, C., Schmidt, S., Kastner, C., Denk, S., Kettler, J., Müller, N., Germer, C., Wolf, E., Gallant, P., & Wiegering, A. (2019) · Neoplasia · doi:10.1016/j.neo.2019.10.003 · Cited by 71
Dissecting transcriptional amplification by MYC
Nie, Z., Guo, C., Das, S., Chow, C. C., Batchelor, E., Simons, S. S., & Levens, D. (2020) · eLife · doi:10.7554/elife.52483 · Cited by 69
Role of Host Cell Factor-1 in cell cycle regulation.
Zargar, Z. U., & Tyagi, S. (2012) · Transcription · doi:10.4161/trns.20711 · Cited by 68
Multiple direct interactions of TBP with the MYC oncoprotein
Wei, Y., Resetca, D., Li, Z., Johansson-Åkhe, I., Ahlner, A., Helander, S., Wallenhammar, A., Morad, V., Raught, B., Wallner, B., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0321-z · Cited by 68
Self-citationResetting cancer stem cell regulatory nodes upon MYC inhibition
Galardi, S., Savino, M., Scagnoli, F., Pellegatta, S., Pisati, F., Zambelli, F., Illi, B., Annibali, D., Beji, S., Orecchini, E., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541489 · Cited by 67
Cossa, G., Röschert, I., Prinz, F., Baluapuri, A., Vidal, R. S., Schülein‐Völk, C., Chang, Y.-C., Ade, C. P., Mastrobuoni, G., Girard, C., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.008 · Cited by 67
Macdonald, J. D., Chacón Simon, S., Han, C., Wang, F., Shaw, J. G., Howes, J. E., Sai, J., Yuh, J. P., Camper, D., Alicie, B. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01411 · Cited by 66
Dingar, D. D., Tu, W. B., Resetca, D., Lourenco, C., Tamachi, A., Melo, J. D., Houlahan, K. E., Kalkat, M., Chan, P.-K., Boutros, P. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05660-0 · Cited by 66
Self-citationEnhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation
Cowling, V. H. (2009) · Oncogene · doi:10.1038/onc.2009.368 · Cited by 64
Ullius, A., Lüscher‐Firzlaff, J., Costa, I. G., Walsemann, G., Forst, A. H., Gusmao, E. G., Kapelle, K., Kleine, H. O., Kremmer, E., Vervoorts, J., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku312 · Cited by 64
Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC
Thomas, L. R., Wang, Q., Grieb, B. C., Phan, J., Bryan, A. F., Sun, Q., Olejniczak, E. T., Clark, T. G., Dey, S., Lorey, S. L., et al. (2018) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2210/pdb6dak/pdb · Cited by 64
Reactivation of Myc transcription in the mouse heart unlocks its proliferative capacity
Bywater, M. J., Burkhart, D. L., Straube, J., Sabò, A., Pendino, V., Hudson, J. E., Quaife-Ryan, G. A., Porrello, E. R., Rae, J., Parton, R. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15552-x · Cited by 64
Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity
Helander, S., Montecchio, M., Pilstål, R., Su, Y., Kuruvilla, J., Elvén, M., Ziauddin, J. M. E., Anandapadamanaban, M., Cristóbal, S., Lundström, P., et al. (2015) · Structure · doi:10.1016/j.str.2015.10.010 · Cited by 62
Self-citationGreber, B. J., & Nogales, E. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-28151-9_5 · Cited by 62
Soodgupta, D., Pan, D., Cui, G., Senpan, A., Yang, X., Lu, L., Weilbaecher, K. N., Prochownik, E. V., Lanza, G. M., & Tomasson, M. H. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0774-t · Cited by 59
Stojanova, A., Tu, W. B., Ponzielli, R., Kotlyar, M., Chan, P.-K., Boutros, P. C., Khosravi, F., Jurišica, I., Raught, B., & Penn, L. Z. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1146836 · Cited by 59
Self-citationBandopadhayay, P., Piccioni, F., O’Rourke, R., Ho, P., Gonzalez, E. M., Buchan, G. B. J., Qian, K., Gionet, G. L., Girard, E. J., Coxon, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10307-9 · Cited by 59
Zhang, N., Ichikawa, W., Faiola, F., Lo, S.-Y., Liu, X., & Martinez, E. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.017 · Cited by 58
Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer
Carabet, L. A., Lallous, N., Leblanc, E., Ban, F., Morin, H., Lawn, S. O., Ghaidi, F., Lee, J., Mills, I. G., Gleave, M. E., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.023 · Cited by 58
Thomas, L. R., Foshage, A. M., Weissmiller, A. M., Popay, T. M., Grieb, B. C., Qualls, S. J., Ng, V. H., Carboneau, L., Lorey, S. L., Eischen, C. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.416 · Cited by 53
Tikhanovich, I., Zhao, J., Bridges, B., Kumer, S. C., Roberts, B., & Weinman, S. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797928 · Cited by 51
Zooming in on Transcription Preinitiation
Gupta, K., Sari, D., Haffke, M., Trowitzsch, S., & Berger, I. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.003 · Cited by 49
ChromNet: Learning the human chromatin network from all ENCODE ChIP-seq data
Lundberg, S., Tu, W. B., Raught, B., Penn, L. Z., Hoffman, M. M., & Lee, S. (2016) · Genome biology · doi:10.1186/s13059-016-0925-0 · Cited by 47
Self-citationJeong, K., Ahn, K.-O., & Yang, C. (2010) · Molecular BioSystems · doi:10.1039/c002534h · Cited by 46
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin
Gherardi, S., Valli, E., Erriquez, D., & Perini, G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00042 · Cited by 45
MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad
Giacomo, S. D., Sollazzo, M., Paglia, S., & Grifoni, D. (2017) · Genes · doi:10.3390/genes8040120 · Cited by 41
Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth
Lustig, L. C., Dingar, D. D., Tu, W. B., Lourenco, C., Kalkat, M., Inamoto, I., Ponzielli, R., Chan, W. C. W., Shin, J. A., & Penn, L. Z. (2017) · Oncogene · doi:10.1038/onc.2017.275 · Cited by 41
Self-citationLü, X., Vogt, P. K., Boger, D. L., & Lunec, J. (2008) · Oncology Reports · doi:10.3892/or.19.3.825 · Cited by 39
Posternak, V., Ung, M. H., Cheng, C., & Cole, M. D. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0247 · Cited by 39
Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
Seo, H. K., Ahn, K.-O., Jung, N.-R., Shin, J., Park, W. S., Lee, K. H., Lee, S.-J., & Jeong, K. (2014) · Oncotarget · doi:10.18632/oncotarget.1545 · Cited by 38
A moving target: structure and disorder in pursuit of Myc inhibitors
Bayliss, R. W., Burgess, S. G., Leen, E. N., & Richards, M. W. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160328 · Cited by 34
Max-E47, a Designed Minimalist Protein That Targets the E-Box DNA Site in Vivo and in Vitro
Xu, J., Chen, G., Jong, A. T. D., Shahravan, S. H., & Shin, J. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901306q · Cited by 31
Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex
Feris, E. J., Hinds, J. W., & Cole, M. D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225784 · Cited by 29
Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1
Jerebtsova, M., Klotchenko, S. A., Артамонова, Т. О., Ammosova, T., Washington, K. N., Egorov, V. V., Shaldzhyan, A. A., Sergeeva, M. V., Zatulovskiy, E. A., Temkina, O. A., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0614-3 · Cited by 23
c-Myc deregulation induces mRNA capping enzyme dependency
Lombardi, O., Varshney, D., Phillips, N. M., & Cowling, V. H. (2016) · Oncotarget · doi:10.18632/oncotarget.12701 · Cited by 23
Targeting c-Myc with a novel Peptide Nuclear Delivery Device
Ting, T. A., Chaumet, A., & Bard, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-73998-x · Cited by 13
[Epidemiology of AIDS and HIV infections in Switzerland].
Samuel, M., Engel, R., Somaini, B., Gurtner, F., & Billo, N. (1988) · PubMed · Cited by 7
Cited by
Emergence of activation or repression in transcriptional control under a fixed molecular context
Martinez-Corral, R., Friedrich, D., Frömel, R., Velten, L., Gunawardena, J., & DePace, A. H. (2024) · doi:10.1101/2024.05.29.596388 · Cited by 18
Williams, E. T., Schiefelbein, K., Schuster, M., Ahmed, I. M. M., De Vries, M., Beveridge, R., Zerbe, O., & Hartrampf, N. (2024) · Chemical Science · doi:10.1039/d4sc00481g · Cited by 13
Zheng, X., Wang, Y., & Qiu, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176840 · Cited by 10
Schütz, S., Bergsdorf, C., Hänni-Holzinger, S., Lingel, A., Renatus, M., Gossert, A. D., & Jahnke, W. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00608 · Cited by 9
Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis
(2022) · doi:10.1158/0008-5472.can-22-0834 · Cited by 6
Metadata
- Authors
- Lourenco, C., Resetca, D., Redel, C., Lin, P., MacDonald, A. S., Ciaccio, R., Kenney, T. M. G., Wei, Y., Andrews, D. W., Sunnerhagen, M., Arrowsmith, C. H., Raught, B., & Penn, L. Z.
- Venue
- Nature Reviews Cancer
- Published
- 2021-06-29
- Volume
- 21
- Issue
- 9
- Pages
- 579-591
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W3173153622
- Cited by
- 347
- References
- 164
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.